NRx's trial of Zyesami to continue enrolment without changes
NRx Pharmaceuticals reported that a US NIH trial analysing Zyesami to treat critical Covid-19 patients will progress to conclude enrolment.
Source: clinicaltrialsarena.com
Page 8 - Preference Management Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Preference Management Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Preference Management Solution Today - Breaking & Trending Today
Pardes reports interim data from Phase I trial of oral Covid-19 antiviral
Pardes Biosciences has reported interim results from the Phase I trial of its oral antiviral drug, PBI-0451, in healthy adult subjects.
Source: clinicaltrialsarena.com
Direct to patient: the rocky road to remote drug delivery in clinical trials
While an obvious solution to lockdown measures, direct-to-patient remote drug delivery is still an untapped opportunity in clinical trials.
Source: clinicaltrialsarena.com
BAXE Launches World's First DeFi Ecosystem with Facial Authentication
Australian fintech startup BAXE has partnered with French technology company IDEMIA and Sydney-based startup Haventec to launch the world’s first DeFi (Decentralized finance) ecosystem with facial authentication.
Source: clinicaltrialsarena.com
Lilly and Evotec enter partnership for metabolic disease drug discovery
Eli Lilly and Evotec have signed a drug discovery partnership within the metabolic diseases field, focusing on kidney diseases and diabetes.
Source: pharmaceutical-technology.com